Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03770468 · ClinicalTrials.gov registry record
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
A clinical trial, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- Completed
- Registry status
- 599
- Enrollment target
NCT03770468 is a clinical trial that has completed, run by European Organisation for Research and Treatment of Cancer - EORTC. The registered enrollment target is 599 participants.
The verdict
NCT03770468 has completed, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- COMPLETED
- Registry status
- 599 participants
- Enrollment target
Study Summary
This pro - and retrospective multicenter clinical epidemiological study studies the molecular genetic, host-derived and clinical determinants of glioblastoma patients with an overall survival of more than 5 years. The different research focusses are: * Identification of clinical parameters and patient characteristics / host-related factors in long-term survivors (Focus 1) * Identification of molecular tumor characteristics in long-term survivors (Focus 2) * Assessment of therapy-related parameters, including neuro-toxicity (Focus 3) * Immunological studies (Focus 4)
Interventions
- PROCEDURE Blood drawl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 599 participants |
| Start Date | 2015-07-05 |
| Est. Completion | 2023-08-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03770468
The ClinicalTrials.gov registry entry for NCT03770468 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 599 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood drawl is the first listed.
NCT03770468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03770468 about?
NCT03770468 is a clinical study titled "Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma". This pro - and retrospective multicenter clinical epidemiological study studies the molecular genetic, host-derived and clinical determinants of glioblastoma patients with an overall survival of more than 5 years. The different research focusses are: * Identification of clinical parameters and pati...
What is the current status of trial NCT03770468?
This trial is currently completed. The enrollment target is 599 participants. The study started on 2015-07-05. Estimated completion is 2023-08-18.
What interventions are being tested in trial NCT03770468?
The interventions under investigation include: Blood drawl (PROCEDURE).
Who is sponsoring clinical trial NCT03770468?
This trial is sponsored by European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.